Top Industry Leaders in the Transcatheter Market
Latest Transcatheter Companies Updates:
Positive Phase 3 results for gepotidacin (GSK): This November 2023 news offers a potential breakthrough in reducing peri-procedural infections during transcatheter procedures.
Positive Phase 2b results for FT515 (Forma Therapeutics): December 2023 news demonstrates FT515's potential in treating advanced Transcatheter Aortic Valve (TAV) degeneration.
Ongoing research on transcatheter tricuspid valve replacement (TVR): Companies like Edwards Lifesciences and Medtronic are actively developing solutions for this challenging area.
The Gitelman Syndrome Foundation collaborates with pharmaceutical companies and research institutions to accelerate clinical trials and advance ATTR research.
List of Transcatheter Key companies in the market:
- Edwards Lifesciences Corporation
- Meril Life Sciences Pvt. Ltd.
- Braile Biomedica
- Venus
- Medtech
- Boston Scientific Corporation
- JenaValve Technology Inc.
- Abbot Laboratories
- Medtronic PLc
- Bracco Diagnostics Inc.